Jump to:
loading...| Preferred Name |
ensartinib |
| Synonyms |
X-396 |
| ID |
http://purl.bioontology.org/ontology/MESH/C000629294 |
| altLabel |
X-396 6-amino-5-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide |
| cui |
C4524311 C3640935 |
| HM |
D011724 D010879 |
| Inverse of RB |
SMA5ZS5B22 |
| isa | |
| Mapped to | |
| MDA |
20181214 |
| MeSH Frequency |
25 |
| MMR |
20181214 |
| notation |
C000629294 |
| PA |
D047428 D000970 |
| prefLabel |
ensartinib |
| SC |
1 |
| Scope Statement |
anaplastic lymphoma kinase (ALK) inhibitor for the treatment of ALK-positive non-small-cell lung cancer |
| SRC |
Future Oncol. 2018 Aug;14(18):1781-1787. |
| TERMUI |
T000949711 T000949710 T000949709 |
| TH |
FDA SRS (2017) USAN (19XX) NLM (2019) INN (19XX) |
| tui |
T109 T121 |
Create New Mapping
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C102754 | National Cancer Institute Thesaurus / 美国国家癌症研究所词典 | LOOM |